Exploiting the molecules and mechanisms of nature to create transformative medicines


Warp Drive Bio is exploiting the molecules and mechanisms of nature to create transformative medicines. The company operates on the core principle that nature is the world’s most powerful inventor of new drugs, unconstrained by the mechanistic and synthetic limitations of traditional medicinal chemistry. Warp Drive Bio is deploying its proprietary Genomic Mining and SMART™ (Small Molecule Assisted Receptor Targeting) platforms, to discover novel medicines that have the potential to make a significant difference in patients’ lives. Warp Drive was acquired by REVOLUTION Medicines, Inc. in 2018.


Year Invested: 2011

Recent News

June 26, 2018
Warp Drive Bio Awarded Composition-of-Matter Patent Covering New Class of Medicines

March 13, 2018
Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference

October 16, 2017
Warp Drive Bio Forms Strategic Collaboration to Advance Novel Classes of Antibiotics to Combat Multi-Drug-Resistant Bacterial Infections

Read More News

Associated Team Members

Alexis Borisy
Partner

Kevin Gillis
Partner/Chief Financial Officer